Compare

Houlihan Lokey/$HLI

1D1W1M3M6MYTD1Y5YMAX

About Houlihan Lokey

Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.
Ticker
$HLI
Sector
Finance
Primary listing
NYSE
Employees
2,800
Website
hl.com

Houlihan Lokey Metrics

BasicAdvanced
$10B
24.69
$5.96
1.01
$2.60
1.90%

What the Analysts think about Houlihan Lokey

Analyst ratings (Buy, Hold, Sell) for Houlihan Lokey stock.
Analyst projections of the future price of Houlihan Lokey stock.

Bulls say / Bears say

Corporate Finance is recovering: Q2 revenue rose 10% year on year as improved M&A and capital-markets conditions lifted average fees. Management said backlog and activity levels point to growth for the rest of FY27. (Houlihan Lokey, The Motley Fool)
Financial and Valuation Advisory adds a steadier growth leg: revenue rose 7% in Q2 and 10% in the first half, with the company citing growth in non-cyclical work in the quarter. This helps diversify earnings beyond dealmaking. (Houlihan Lokey)
Restructuring could become a countercyclical growth source: management expects revenue to rise into FY2028 as its backlog builds, supported by software-sector distress and looming debt maturities. (The Motley Fool)
The recovery is not yet reflected across the full year: first-half revenue fell 5% and net income attributable to Houlihan Lokey dropped 11% year on year, despite the latest quarter’s revenue rebound. That shows how uneven deal timing can weigh on results. (SEC)
Financial Restructuring remains weak: Q2 revenue fell 12% and closed transactions declined to 27 from 37. The anticipated pipeline recovery has not yet translated into higher fees. (Houlihan Lokey, The Motley Fool)
Costs are squeezing earnings conversion: Q2 revenue rose 5%, but net income attributable to the company fell 2%. Non-compensation expenses climbed 14%, faster than revenue, which could constrain margins if that trend persists. (SEC)
Data summarised monthly by Lightyear AI. Last updated on 4 Nov 2026.

Houlihan Lokey Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Houlihan Lokey Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Houlihan Lokey

AllUSDEURGBP
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.